Christopher David Ozeroff serves as Executive at ARCA biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Christopher David Ozeroff has executed 14 insider transactions totaling $128.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 22, 2021 involved purchasing 50,000 shares valued at $113.0K.
Christopher David Ozeroff currently holds 50,970 shares of ARCA biopharma, Inc. (ABIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher David Ozeroff has been a net buyer of ABIO stock. They have purchased $113.0K and sold $15.7K worth of shares.
Christopher David Ozeroff's most recent insider trade was on Nov 22, 2021, when they purchased 50,000 shares at $2.26 per share.
Get notified when new Form 4 filings are submitted
| $2.41 |
| Discretionary |
| Feb 28, 2017 | ABIO | $1.2K | Sale | 465 | $2.61 | Discretionary |
| Sep 20, 2016 | ABIO | $3.4K | Sale | 1,185 | $2.89 | Discretionary |
| Apr 5, 2016 | ABIO | $1.3K | Sale | 366 | $3.52 | Discretionary |
| Mar 1, 2016 | ABIO | $1.6K | Sale | 458 | $3.51 | Discretionary |
| Sep 18, 2015 | ABIO | $7.1K | Sale | 1,129 | $6.32 | Discretionary |
| Feb 12, 2015 | ABIO | $0 | Award | 24,050 | $N/A | Discretionary |
| Feb 27, 2014 | ABIO | $66.7K | Award | 34,200 | $1.95 | Discretionary |
| Sep 17, 2013 | ABIO | $103.5K | Award | 75,000 | $1.38 | Discretionary |
| Oct 22, 2012 | ABIO | $24.8K | Award | 63,475 | $0.39 | Discretionary |
| Jul 7, 2010 | ABIO | $0 | Other | 2,051 | $N/A | Discretionary |
| Jul 2, 2010 | ABIO | $246 | Option Exercise | 4,101 | $0.06 | Discretionary |
| May 26, 2010 | ABIO | $0 | Other | 39,709 | $N/A | Discretionary |